Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-390-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 2aug1993 / 12jan1994
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP-compliant guideline study, no restrictions, fully adequate for assessment.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine
- EC Number:
- 219-145-8
- EC Name:
- N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine
- Cas Number:
- 2372-82-9
- Molecular formula:
- C18H41N3
- IUPAC Name:
- N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine
- Reference substance name:
- Triamine Y12
- IUPAC Name:
- Triamine Y12
- Details on test material:
- - Name of test material (as cited in study report): P4150
- Physical state: colourless liquid
- Analytical purity: 30.2% aqueous solution
- Lot/batch No.: PN-93-12
- Storage condition of test material: in the dark at ambient temperature
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Limited, Margate, Kent, England
- Age at study initiation: ca. 9 weeks
- Weight at study initiation: ca. 245 g (males), ca. 9 weeks (females)
- Fasting period before study:
- Housing: females: individually in polypropylene cages with stainless steel grid bottoms and mesh tops, measuring 42 x 27 x 20 cm. Prior to mating females were housed in pairs in this type of cage. Males: singly in cages of similar design, measuring 58 x 38.5 x 20 cm.
- Diet : Rat and Mouse Breeder Diet No. 3 (Expanded) SQC, ad libitum
- Water: domestic mains water, ad libitum
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 ± 2
- Humidity (%): 50 ± 15
- Air changes (per hr): 15-20
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Fresh solutions were prepared daily. For high concentration group, the requisite quantity of the test material was weighed into a labelled container. The necessary volume of vehicle was added, and mixing was by inversion, as required. For lower concentrations aliquots of the high dose solution were diluted with the vehicle to give required concentrations.
VEHICLE
- Amount of vehicle (if gavage): 10 mL/kg bw
- Concentration in vehicle: 2.5, 7.7, 20 mg/mL (calculated for pure substance) - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- A single 10 mL sample was taken from each concentration on the 1st and 8th day of dosing and triplicate sub-samples were analyzed for concentration and homogeneity in the IRI Analytical Chemistry Laboratory by method # 7034.
- Details on mating procedure:
- - Impregnation procedure: cohoused
- If cohoused:
- M/F ratio per cage: 1:2
- Length of cohabitation: continuous until mating was detected
- Verification of same strain and source of both sexes: yes
- Proof of pregnancy: vaginal plug or sperm in vaginal smear referred to as day 0 - Duration of treatment / exposure:
- Gestations Day 6-16
- Frequency of treatment:
- daily
- Duration of test:
- Until Day 20 of gestation
- No. of animals per sex per dose:
- 25 females/dose
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: based on a separate dose range finding study
- Rationale for animal assignment (if not random): computer generated series of randomly sequenced numbers, ensuring that siblings and females mated by the same male were not placed in the same treatment group.
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily. In addition animals were checked for viability at the beginning of each day and as late as possible on each day.
BODY WEIGHT: Yes
- Time schedule for examinations: days 0, 6, 9, 13, 17 and 20 of gestation
FOOD CONSUMPTION AND COMPOUND INTAKE: Yes
- Time schedule for examinations: daily, commencing on Day 3 of gestation
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day # 20
- Organs examined: the contents of thoracic and abdominal cavity - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes - Fetal examinations:
- - External examinations: Yes, all per litter
- Soft tissue examinations: Yes, all per litter
- Skeletal examinations: Yes, half per litter
- Head examinations: No - Statistics:
- Weight gain was analysed using the Kruskal-Wallis test, with comparisons with the control using a modified Dunn's procedure. Food consumption was analysed by parametric analysis of variance, with homogeneity of variance checked using Levene's test and normality of data by the Shapiro-Wilk test. Comparisons with the control were made using Dunnett's t-test. For all other parameters, interpretation was based on examination of the individual and group mean values.
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:yes
Details on maternal toxic effects:
All animals at 200 mg/kg/day test material (corresponding to 60 mg/kg bw/day pure substance) and many at 75 mg/kg/day (corresponding to 22.5 mg/kg bw/day pure subtance) showed reaction to treatment. The principle findings were dyspnoea, salivation with associated brown staining, piloerection and indications of reduced activity (such as hunched, ataxic and cold to touch). Two animals at 200 mg/kg/day were killed prematurely: necropsy findings included intestinal distension, and therefore the similar distension observed for a further animal was also considered to be associated with treatment. The other clinical observations and necropsy findings were considered to be either associated with the above findings or to be incidental.
There was a dose related reduction in weight gain over the dosing period at 75 and 200 mg/kg/day (corresponding to 22.5 and 60 mg/kg bw/day pure substance), which had become apparent by Day 9 of gestation. At 200 mg/kg/day, weight gain over Days 6-17 was significantly lower than control (P<0.0 1) and 5 animals at this level showed weight loss between Days 9 and 13 of gestation. Gain over Days 6-17 at 75 mg/kg/day, although lower than control, was not statistically significant (P> 0.05).
Body weight performance at 25 mg/kg bw/day (corresponding to 7.5 mg/kg bw/day) was essentially similar to control.
There was a reduction in food consumption at 200 mg/kg/day, which persisted throughout the dosing period. At 75 mg/kg/day, food consumption was marginally reduced. At both these levels, food consumption over the dosing period was significantly lower than control (P<0.01).
Food consumption at 25 mg/kg/day was similar to Control.
Effect levels (maternal animals)
- Dose descriptor:
- NOAEL
- Effect level:
- 7.5 mg/kg bw/day (actual dose received)
- Based on:
- act. ingr.
- Basis for effect level:
- other: maternal toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effects
Details on embryotoxic / teratogenic effects:
The mean number of implants at 25 and 75 mg/kg/day (corresponding to 7.5 and 22.5 mg/kg bw/day pure substance) was slightly lower than control or at 200 mg/kg/day (corresponding to 60 mg/kg bw/day pure substance). However, this could not be attributed to treatment because the number of implants would have been established prior to commencement of treatment.
The incidence of early embryonic deaths, and hence of total dead implants was greater at 200 mg/kg/day (60 mg/kg bw/day pure substance) than in control. This increase was largely associated with three animals which had large numbers of early deaths. The incidence of dead implants at 25 and 75 mg/kg/day (7.5 and 22.5 mg/kg bw/day pure substance) was similar to control.
Mean foetal weight at 200 mg/kg/day (60 mg/kg bw/day pure substance) was slightly lower than control, with the difference approaching but not achieving statistical significance(P>0.05).
The number and type of major foetal abnormalities were considered to be typical of those seen in historical data. Taken together, the incidences of minor abnormalities and variants were typical of those that would be expected from historical data and were similar in all groups. The group values indicating the state of skeletal ossification were similar in all groups. Slight differences were considered too small to be attributed to treatment.
Effect levels (fetuses)
- Dose descriptor:
- NOAEL
- Effect level:
- 22.5 mg/kg bw/day (actual dose received)
- Based on:
- act. ingr.
- Basis for effect level:
- other: embryotoxicity
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of the study no teratogenic effects (as indicated by the incidences of foetal malformations, anomalies and variants) were found up to 200 mg P4150/kg/day (60 mg a.i./kg/day) of the test substance.
- Executive summary:
- Based on Guidelines: OECD 414 and EPA-FIFRA 83-3 100 mated female and 60 male rats were used for the study. After mating females were housed singly with separate food and water for each cage. Batches of diet and water were analysed throughout the study. Pairing was on the basis of one male to two females. For each female cohabitation with a male was continuous until mating was detected. A vaginal lavage was examined each morning and the day of detection of sperm in the lavage, or of a copulatory plug in situ was considered to be Day 0 of gestation. On detection of mating, females were randomly assigned to treatment grou ps. The treatment groups were arranged as follows: Group no. Treatment/dose level mg P4150/kg/day Animal nos. 1 Control 0 1-25 2 Low dose 25 26-50 3 Intermediate 75 51-75 4 High 200 76_100,160* *Replacement animal following death of animal no. 86 Dose levels were determined from the results of a separate dose finding study in rats. In the study, very slight maternal toxicity was demonstrated in mated animals at 100 and 150 mg/kg/day. However, unequivocal toxicity was seen in a supplementary group of unmated animals at 200 mg/kg/day. There was no obvious effect on pregnancy performance or foetal weight in the mated animals. Females were dosed orally by gavage at a volume of 10 ml dosing solution per kg of body weight using a steel dosing cannula. The volume of solution to be administered each day was determined each day by the weight of the animal as measured at the time of administration. The animals were dosed once daily at approximately the same time each day over Days 6— 16 inclusive of gestation. The test material was formulated as a solution in water. Fresh solutions were prepared daily. A 10 ml sample from each concentration was taken on the first and eight day of dosing for analysis for concentration, homogeneity and stability. Clinical observations were recorded for reaction to treatment each day. In addition all animals were checked for viability at the beginning and end of each day. Individual body weights were recorded on Days 0, 6, 9, 13, 17 and 20 of gestation. The weight of food consumed by each mated female was recorded daily, commencing on Day 3 of gestation. Females were killed by carbon dioxide asphyxiation. Foetuses were killed by chilling at ca 4°C for ca 5 mm before fixation. Animals that died prematurely during the study were examined at necropsy and included examination of the cranial contents. Other necropsies were conducted on Day 20 of gestation but did not include cranial examination. The thoracic and abdominal cavities were inspected and any lesions were described, samples were taken where necessary. The reproductive tract was weighed intact, with examination of the uterus contents. The number and position of all implants was recorded. Each implant was classified as being live, a foetal death, i.e. death occurred after day 16 of gestation, or an early embryonic death, i.e. only placental remains or a decidual scar visible. The number of corpora lutea graviditatis in each ovary were recorded. Each live foetus within the litter was individually identified and its weight recorded. The foetuses were examined for externally visible abnormalities. Half the foetuses were fixed in methylated ethyl alcohol and examined for occurrence of gross visceral abnormalities. These foetuses were then cleared in potassium hydroxide and glycerol and the skeletons stained with Alizarin Red S for examination for abnormalities and variants, including state of ossification. The other half of the foetuses were fixed in Bouin’s fluid and examined for visceral abnormalities by a free-hand serial sectioning technique from that of (1965) Teratology: Principles and Techniques, The of . The sex of the foetus was determined during the visceral examination. Statistical analysis was used where appropriate. Weight gain was analysed using the Kruskal-Wallis test, with comparisons with the control using a modified Dunn’s procedure. Food consumption was analysed by parametric analysis of variance, with homogeneity of variance checked using Levene’s test and normality of data by the Shapiro-Wilk test. Comparisons with the Control were made using Dunnett’s t-test. For all other parameters, interpretation was based on examination of the individual and group mean values. Maternal toxicity was indicated at 75 and 200 mg P4150/kg/day by reduced body weight gain and food consumption and by clinical reactions to treatment, which in 2 animals at 200/kg/day required premature sacrifice: dyspnoea, salivation with associated brown staining, piloerection and indications of reduced activity (such as hunched, ataxic and cold to touch).. At 200 mg/kg/day, there was an increased incidence of early embryonic deaths: the 3 females with the greatest number of early deaths were all among the 5 females showing weight loss between Days 9 and 13 of gestation, suggesting that the early deaths may have been secondary to maternal toxicity. Mean foetal weight at this level was slightly lower than Control. At 25 and 75 mg/kg/day, there were no obvious effects on pregnancy performance or foetal weight. The incidences of foetal malformations, anomalies and variants were essentially similar in all groups.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)